Cardiomyopathies and heart failure : biomolecular, infectious, and immune mechanisms / edited by Akira Matsumori.
Series: Developments in cardiovascular medicine ; v. 248Publication details: Boston : Kluwer Academic Publishers, c2003.Description: xix, 531 p. : ill. (some col.) ; 24 cmISBN:- 1402074387 (hbk. : alk. paper)
- Myocardium -- Pathophysiology
- Myocardium -- Diseases -- Molecular aspects
- Myocardium -- Diseases -- Immunological aspects
- Heart failure -- Pathophysiology
- Heart failure -- Molecular aspects
- Heart failure -- Immunological aspects
- Myocardial Diseases -- immunology
- Heart Failure, Congestive -- etiology
- Heart Failure, Congestive -- immunology
- Heart Failure, Congestive -- therapy
- Myocardial Diseases -- etiology
- Myocardial Diseases -- therapy
- WG 280
| Item type | Current library | Call number | Copy number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
Book Open Access
|
Health Sciences Library | WG 280 C26668 2003 (Browse shelf(Opens below)) | 1 | Available | MBAL22010362 |
Includes bibliographical references and index.
Contents
I: Introductory Chapter.
Cardiomyopathies and Heart Failure: Biomolecular, Infections and Immune Mechanisms; A. Matsumori.
II: Cytokines in Cardiomyopathies and Heart Failure.
1. Chemokines and Cardiovascular Diseases; K. Matsushima, et al.
2. Negative Regulator of Cytokine Signaling (SOCS) Genes in Inflammation; I. Kinjyo, et al.
3. The Interleukin-6 Family of Cytokines and their Receptors in Patients with Congestive Heart Failure; K. Yamauchi-Takihara, et al.
4. Animal Model of Cardiomyopathy Due to Overexpression of TNF-alpha; T. Kubota.
III: Autoimmunity in Cardiomyopathies and Heart Failure.
5. Myosin Autoreactive T Cells and Autoimmune Myocarditis: Lessons from the Disease Caused by Cardiac Myosin Peptide CM2; T. Izumi, et al. 6. Autoimmunity in Cardiomyopathies; M. Noutsias, et al.
7. Anti-G-Protein Coupled Cardiac Receptor Autoantibodies in Dilated Cardiomyopathy; M. Fu.
8. Clinical Significance of Circulating Cardiac Autoantibodies in Dilated Cardiomyopathy and Myocarditis; A.L.P. Caforio, W.J. McKenna.
IV: Mast Cell Mediators and Human Diseases: Basic Aspects.
9. Development of Mast Cells: Process and Regulatory Mechanisms; Y. Kitamura, et al.
10. Mast Cells in Experimental Myocardial Infarction; N.G. Frangogiannis, M.L. Entman.
11. possible Involvement of Mast Cells in the Development of Fibrosis; M. Kurosawa, et al.
12. Human Mast Cell Chymase and 31 Amino Acid Endothelin-1; H. Kido, et al. 13. Tryptase from Human mast Cells; L.B. Schwartz.
14. Effects of the Tryptase Receptor Activating Peptide and Antibodies against the Tryptase Receptor PAR-2 on Neonatal Rat Cardiomyocytes in Culture; G. Wallukat, et al.
V: Mast Cell Mediators and Human Diseases Clinical Aspects.
15. Role of Human Heart Mast Cells in Immunologic and Inflammatory Mechanisms Underlying Cardiovascular Disorders; G. Marone, et al. 16. Mast Cells in Atherosclerotic Human Coronary Arteries: Implications for Coronary Fatty Streak Formation and Plaque Erosion or Rupture; P.T. Kovanen, et al.
17. The Key Role of Mast Cells in the Evolution to Congestive Heart Failure; M. Hara, et al.
VI: Viral Etiology of Cardiomyopathies and Heart Failure.
18. Links between Viral Infections and Heart Disease; C.J. Gauntt, et al.
19. Molecular Detection and Characterization of Human Enteroviruses; M.A. Pallansch, M.S. Oberste.
20. Detection and Biological Implications of Genetic Memeory in Viral Quasispecies; E. Domingo, et al.
21. The Group B Coxsackieviruses as Vaccines and Vectors; N.M. Chapman, et al.
22. Detection of Important Diagnostic Markers of HCV Infection; H.A. Fields.
VII: Diagnosis and Treatment of Myocarditis.
23. Large Animal Model of Viral Myocarditis; M.K. Njenga, et al.
24. Hepatitis C Virus and Cardiomyopathy; Y. Sato, et al.
25. Diagnosis and Treatment of Myocarditis: The Role of Adenovirus Infection in Cardiomyopathy and Heart Failure; J.A. Towbin, N.E. Bowles. 26. The Natural History of Viral Myocarditis: Pathogenic Role of Adrenergic System Dysfunction in the Development of Idiopathic Dilated Cardiomyopathy; P.M. Seferovic, et al.
27. Clinical Diagnosis of Myocarditis; G.W. Dec.
28. Recent Advances in Giant Cell Mytosis; L.T. Cooper Jr.
29. Registry of Myocarditis and Heart Failure; Min Nian, et al.
VIII: Molecular and Genetic Analyses in Heart Disease.
30. Molecular Etiology of Idiopathic Cardiomyopathy; A. Kimura, et al.
31. Gene-Based Therapy of Long QT Syndrome; J.W. Mason.
IX: The Future in the Management of Cardiomyopathies and Heart Failure.
32. How does Adenosine Mediate Cardioprotection? M. Kitkaze, et al.
33. Protection of Cell Injury by Thioredoxin; K. Shioji, et al.
34. Hematopoietic Stem Cells and Angiogenesis; N. Takakura.
35. Transplanting Cells for the Treatment of Cardiomyopathy; K. Tambara, et al.
36. Toward an Ideal Large Animal Model of Dilated Cardiomyopathy to Study Left Ventricular Volume Reduction Surgery; T. Koyama, et al.
37. Heart Transplantation: 35 Years of Progress; R.J. Rodeheffer.
38. Genes of the Major Histcompatability Complex Class II Influence the Phenotype of Cardiomyopathies Associated with Hepatitis C Virus Infection; A. Matsumori, et al.
There are no comments on this title.